MR and cerebrospinal fluid enzymes as sensitive indicators of subclinical cerebral injury after open-heart valve replacement surgery

American Journal of Neuroradiology

Volumn 17, Issue 2, 1996, Pages 205-212

  Steinberg, Gary K ^a,b   De La Paz, Robert ^a   Scott Mitchell, R ^a   Bell, Teresa E ^a   Albers, Gregory W ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Brain, ischemia; Cerebrospinal fluid; Heart; Iatrogenic disease or disorder; Magnetic resonance, postoperative

Indexed keywords

ADENYLATE KINASE; CREATINE KINASE; LACTATE DEHYDROGENASE; NEURON SPECIFIC ENOLASE;

ADULT; AGED; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; FEMALE; HEART VALVE REPLACEMENT; HUMAN; LUMBAR PUNCTURE; MALE; MEDICAL RECORD; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PROSPECTIVE STUDY; VALVULAR HEART DISEASE;

ADENYLATE KINASE; ADULT; AGED; AGED, 80 AND OVER; BRAIN; BRAIN DAMAGE, CHRONIC; CARDIOPULMONARY BYPASS; CREATINE KINASE; ENZYMES; FEMALE; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HUMANS; HYPOXIA, BRAIN; L-LACTATE DEHYDROGENASE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PHOSPHOPYRUVATE HYDRATASE; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES;

EID: 0030059310     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Reves JG, Croughwell N, Jacobs JR, Greeley W. Anesthesia during cardiopulmonary bypass: does it matter? In: Tinker JH, ed. Cardiopulmonary Bypass: Current Concepts and Controversies. Philadelphia: Saunders, 1989:69-97
2. Coffee CE, Massey EW, Roberts KB, Curtis S, Jones RH, Pryor DB Natural history of cerebral complications of coronary artery bypass graft surgery. Neurology 1983;33:1416-1421
3. Aberg T, Ronquist G, Tydén H, et al. Adverse effects on the brain in cardiac operations as assessed by biochemical, psychometric, and radiologic methods J Thorac Cardiovasc Surg 1984;87:99-105
4. Aberg T, Ronquist G, Tydén H. Ahlund P, Bergström K. Release of adenylate kinase into cerebrospinal fluid during open-heart surgery and its relation to postoperative intellectual function. Lancet 1982;1:1139-1142
5. Furlan AJ, Breuer AC. Central nervous system complications of open heart surgery Stroke 1984;15:912-915
6. Shaw PJ, Bates D. Cartlidge NEF, et al. Neurologic and neuropsychological morbidity following major surgery: comparison of coronary artery bypass and peripheral vascular surgery. Stroke 1987;18:700-707
7. Harrison MJG, Schneidau A, Ho R, Smith PLC, Newman S, Treasure T. Cerebrovascular disease and functional outcome after coronary artery bypass surgery. Stroke 1989;20:235-237
8. Newman M, Frasco P, Kern F, Greeley WJ, Blurnenthal JA, Reves JG. Central nervous system dysfunction after cardiac surgery. Adv Cardiac Surg 1992;3:243-284
9. Brant-Zawadzki M, Weinstein P, Bartkowski H, Moseley M. MR imaging and spectroscopy in clinical and experimental cerebral ischemia: a review. AJNR Am J Neuroradiol 1987;148:579-588
10. Vaagenes P, Kjekshus J, Sivertsen E, Semb G. Temporal pattern of enzyme changes in cerebrospinal fluid in patients with neurologic complications after open heart surgery. Crit Care Med 1987;15:726-731
11. Sotaniemi KA, Mononen H, Hokkanen TI. Long-term cerebral outcome after open-heart surgery: a five year neuropsychological follow-up study. Stroke 1986;17:410-416
12. Sotaniemi KA, Sulg I, Hokkanen TE. Quantitative EEG as a measure of cerebral dysfunction before and after open-heart surgery. Electroenceph Clin Neurophysiol 1980;50:81-95
13. Hise JH, Nipper ML, Schnitker JC. Stroke associated with coronary artery bypass surgery. AJNR Am J Neuroradiol 1991;12:811-814
14. Blauth CI, Smith PL, Arnold JV, Jagoe JR, Wootten R, Taylor KM. Influence of oxygenator type on the prevalence and extent of microembolic retinal ischemia during cardiopulmonary bypass: assessment by digital image analysis. J Thorac Cardiovasc Surg 1990;99:61-69
15. Moody DM, Bell MA, Challa VR, Johnston WE, Prough DS. Brain microemboli during cardiac surgery or aortography. Ann Neurol 1990;28:477-486
16. Boyajian RA, Sobel DF, DeLaria GA, Otis SM. Embolic stroke as a sequela of cardiopulmonary bypass. J Neuroimag 1993;3:1-5
17. Padayachee TS, Parsons S, Theobold R, Linley J, Gosling RG, Deverall PB. The detection of microemboli in the middle cerebral artery during cardiopulmonary bypass: a transcranial Doppler ultrasound investigation using membrane and bubble oxygenators. Ann Thorac Surg 1987;44:298-302
18. Slogoff S, Girgis KZ, Keats AS. Etiologic factors in neuropsychiatric complications associated with cardiopulmonary bypass. Anesth Analg 1982;61:903-91
19. Nussmeier NA, Arlund C, Slogoff SL. Neuropsychiatric complications after cardiopulmonary bypass: cerebral protection by a barbiturate. Anesthesiology 1986;64:165-170
20. Schmidt R, Fazekas F, Offenbacher H, et al. Brain magnetic resonance imaging in coronary artery bypass grafts: a pre- and postoperative assessment. Neurology 1993;43:775-778
21. McConnell JR, Fleming WH, Chu WK, et al. Magnetic resonance imaging of the brain in infants and children before and after cardiac surgery. Am J Dis Child 1990;144:374-378
22. Simonson TM, Yuh WTC, Hindman BJ, Embrey RP, Halloran JI, Behrendt DM. Contrast MR of the brain after high-perfusion cardiopulmonary bypass. AJNR: Am J Neuroradiol 1994;15:3-7
23. Muraoka R, Yokota M, Aoshima M, et al. Subclinical changes in brain morphology following cardiac operations as reflected by computed tomographic scans of the brain. J Thorac Cardiovasc Surg 1981;81:354-369
24. Pullicino PM, Bhayana G, Lajos T, Bergsland J, Schachter M, Simon J. White matter hyperintensities and hypotension in coronary bypass surgery. Cerebrovasc Dis 1992;2:230
25. Awad IA, Johnson PC, Spetzler RF, Hodak JA. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly, II: postmortem pathological correlations. Stroke 1986;17:1090-1097
26. Braffman BH, Zimmerman RA, Trojanowski JQ, Gonatas NK, Hickey WF, Schlaepfer WW. Brain MR: pathologic correlation with gross and histopathology, 2: hyperintense white-matter foci in the elderly. AJNR Am J Neuroradiol 1988;9:629-636
27. Fazekas F, Niederkorn K, Schmidt R, et al. White matter signal abnormalities in normal individuals: correlation with carotid ultrasonography, cerebral blood flow measurements, and cerebrovascular risk factors. Stroke 1988;19:1285-1288
28. Yamauchi H, Fukuyama H, Harada K, et al. White matter hyperintensities may correspond to areas of increased blood volume: correlative MR and PET observations. J Comput Assist Tomogr 1990;14:905-908
29. Van Swieten JC, van den Hout JHW, van Ketel BA, Hijdra A, Wokke JHJ, van Gijn J. Penventricular lesions in the white matter on magnetic resonance imaging in the elderly: a morphometric analysis of arteriolosclerosis and dilated perivascular spaces. Brain 1991;114:761-774
30. Fazekas F, Kleinert R, Offenbacher H, et al. The morphologic correlate of incidental punctate white matter hyperintensities on MR images. AJNR Am J Neuroradiol 1991;12:915-921
31. Awad IA, Masaryk T, Magdinec M. Pathogenesis of subcortical hyperintense lesions on magnetic resonance imaging of the brain: observations in patients undergoing controlled therapeutic internal carotid artery occlusion. Stroke 1993;24:1339-1346
32. Hay E, Royds JA, Davies-Jones GAB, Lewtas MA, Timperley WR, Taylor CB. Cerebrospinal fluid enolase in stroke. J Neurol Neurosurg Psychiatry 1984;47:724-729
33. Koh J, Choi DW. Quantitative determination of cortical neuronal injury in cell culture by factale dehydrogenase efflux assay. J Neurosci 1987;20:83-90
34. Persson L, Hardemark H-G, Gustafsson J, et al. S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system. Stroke 1987;18:911-918
35. Jacobi C, Reiber H. Clinical relevance of increased neuron-specific enolase concentration in cerebrospinal fluid. Clin. Chim Acta 1988;177:49-54
36. Hardemark H-G, Ericsson N, Kotwica Z, et al. S-100 protein and neuron-specific enolase in CSF after experimental traumatic or focal ischemic brain damage. J Neurosurg 1989;71:727-731
37. Albers GW, Goldberg MP, Choi DW. N-Methyl-D-aspartate antagonists: ready for clinical trial in brain ischemia? Ann Neurol 1989;25:398-403
38. Steinberg GK, Kunis D, Saleh J. DeLaPaz R. Protection after transient focal cerebral ischemia by the N-methyl-D-aspartate antagonist dextrorphan is dependent upon plasma and brain levels. J Cereb Blood Flow Metab 1991;11:1015-1024